Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey
Journal of Antimicrobial Chemotherapy · 2023
DOI: 10.1093/jac/dkad010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Doreen Kamori und 25 weiteren Autor:innen. Beteiligte Einrichtung: Muhimbili University of Health and Allied Sciences, P.O. Box 650001, Dar es Salaam, Tanzania. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, HIV-1, HIV Integrase. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: The Global Fund to Fight AIDS, Tuberculosis and Malaria.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Despite the scale-up of ART and the rollout in Tanzania of dolutegravir, an integrase strand transfer inhibitor (INSTI), treatment success has not been fully realized. HIV drug resistance (HIVDR), including dolutegravir resistance, could be implicated in the notable suboptimal viral load (VL) suppression among HIV patients.
Objectives
To determine the prevalence and patterns of acquired drug resistance mutations (DRMs) among children and adults in Tanzania.
Methods
A national cross-sectional HIVDR survey was conducted among 866 children and 1173 adults. Genotyping was done on dried blood spot and/or plasma of participants with high HIV VL (≥1000 copies/mL). HIV genes (reverse transcriptase, protease and integrase) were amplified by PCR and directly sequenced. The Stanford HIVDR Database was used for HIVDR interpretation.
Results
HIVDR genotyping was performed on blood samples from 137 participants (92 children and 45 adults) with VL ≥ 1000 copies/mL. The overall prevalence of HIV DRMs was 71.5%, with DRMs present in 78.3% of children and 57.8% of adults. Importantly, 5.8% of participants had INSTI DRMs including major DRMs: Q148K, E138K, G118R, G140A, T66A and R263K. NNRTI, NRTI and PI DRMs were also detected in 62.8%, 44.5% and 8% of participants, respectively. All the participants with major INSTI DRMs harboured DRMs targeting NRTI backbone drugs.
Conclusions
More than 7 in 10 patients with high HIV viraemia in Tanzania have DRMs. The early emergence of dolutegravir resistance is of concern for the efficacy of the Tanzanian ART programme.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Muhimbili University of Health and Allied Sciences, P.O. Box 650001, Dar es Salaam, Tanzania.
- Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
- Internal Medicine Department, Muhimbili National Hospital, Dar es Salaam, Tanzania.
- National AIDS Control Programme, Directorate of Preventive Services, Ministry of Health, Dodoma, Tanzania.
- Division of Global HIV & Tuberculosis, US Centers for Disease Control and Prevention, Dar es Salaam, Tanzania.
- Management and Development for Health, Dar es Salaam, Tanzania.
ORCID-Profile: Takamasa Ueno
Förderung
- The Global Fund to Fight AIDS, Tuberculosis and Malaria
Zitieren
APA
Kamori, D., Barabona, G., Rugemalila, J., Maokola, W., Masoud, S. S., Mizinduko, M., Sabasaba, A., Ruhago, G., Sambu, V., Mushi, J., Mgomella, G. S., Mcollogi, J. J., Msafiri, F., Mugusi, S., Boniface, J., Mutagonda, R., Mlunde, L., Amani, D., Mboya, E., …, & Sunguya, B. (2023). Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad010
Vancouver
Kamori D, Barabona G, Rugemalila J, Maokola W, Masoud SS, Mizinduko M, et al. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad010
BibTeX
@article{Kamori2023,
author = {Kamori, Doreen and Barabona, Godfrey and Rugemalila, Joan and Maokola, Werner and Masoud, Salim S and Mizinduko, Mucho and Sabasaba, Amon and Ruhago, George and Sambu, Veryeh and Mushi, Jeremiah and Mgomella, George S and Mcollogi, James J and Msafiri, Frank and Mugusi, Sabina and Boniface, Jullu and Mutagonda, Ritah and Mlunde, Linda and Amani, Davis and Mboya, Erick and Mahiti, Macdonald and Rwebembera, Anath and Ueno, Takamasa and Pembe, Andrea and Njau, Prosper and Mutayoba, Beatrice and Sunguya, Bruno},
title = {Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
doi = {10.1093/jac/dkad010}
}
EUVIMED